2022
Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding
Li D, Ong S, Hughes M, Hung K, Agarwal R, Alexis J, Damianos J, Sharma S, Pires J, Nanna M, Laine L. Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics 2022, 57: 94-102. PMID: 36394111, DOI: 10.1111/apt.17278.Peer-Reviewed Original ResearchConceptsMajor adverse cardiovascular eventsGastrointestinal bleedingPrimary preventionCardiovascular eventsRisk of MACEYale-New Haven HospitalPrimary cardiovascular preventionAdverse cardiovascular eventsKaplan-Meier curvesLong-term outcomesRisk-benefit ratioLog-rank testAspirin 81Hospitalised patientsPrimary endpointSecondary endpointsCardiovascular preventionSubsequent hospitalisationMedian ageDeprescriptionHigh riskAspirinHospitalisationPatientsPrevention
2020
Weight change in heart failure inpatients not associated with 30-day readmission
Nanna MG, Sullivan AE, Bazylevska V, Wong R, Murphy TE, Bellumkonda L, McNamara RL. Weight change in heart failure inpatients not associated with 30-day readmission. Future Cardiology 2020, 16: 289-296. PMID: 32286858, PMCID: PMC7607390, DOI: 10.2217/fca-2019-0047.Peer-Reviewed Original ResearchConceptsHF-specific readmissionsHeart failureWeight changeWeight lossHeart failure inpatientsHospital weight lossDecompensated heart failureShort-term readmissionHF inpatientsCause readmissionDischarge weightSingle centerReadmissionLogistic regressionPatientsInpatientsCauseAssociationWeight dataAdmission